Category: <span>Galinpepimut-S</span>

Category: Galinpepimut-S

American Society of Clinical Oncology (ASCO), Galinpepimut-S, International Mesothelioma Interest Group, M.D. Anderson Cancer Center, malignant pleural mesothelioma, Memorial Sloan-Kettering Cancer Center, mesothelioma cancer, Mesothelioma News, U.S. Food and Drug Administration (FDA)

FDA Fast Tracks New Pleural Mesothelioma Drug

 

The U.S. Food & Drug Administration (FDA) has decided to fast track SELLAS™ Life Sciences’ new drug Galinpepimut-S to treat pleural mesothelioma